Cargando…

Long Non-Coding RNAs in Oral Submucous Fibrosis: Their Functional Mechanisms and Recent Research Progress

Many studies have shown that most genomes are transcribed into non-coding RNAs (ncRNAs), including microRNAs (miRs) and long non-coding RNAs (lncRNAs), which can affect different cell characteristics. LncRNAs are long heterologous RNAs that regulate gene expression and various signaling pathways dur...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Yaodong, Wang, Wei, Jiang, Pingping, Yang, Lin, Guo, Qi, Xiang, Junwei, Gao, Yuling, Wang, Yuanyin, Chen, Ran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578048/ https://www.ncbi.nlm.nih.gov/pubmed/34764671 http://dx.doi.org/10.2147/JIR.S337014

Ejemplares similares

Research Achievements of Oral Submucous Fibrosis: Progress and Prospect
por: Xu, Hui, et al.
Publicado: (2021)

The Functional Mechanism of MicroRNA in Oral Lichen Planus
por: Li, Yunshan, et al.
Publicado: (2022)

The functional roles of microRNAs in the pathogenesis of oral submucous fibrosis
por: Hsieh, Pei-Ling, et al.
Publicado: (2022)

Long Non-Coding RNA Expression Profile Associated with Malignant Progression of Oral Submucous Fibrosis
por: Zhou, Shanghui, et al.
Publicado: (2019)

Oral submucous fibrosis: an update
por: Wollina, Uwe, et al.
Publicado: (2015)

Oral submucous fibrosis: An update
por: Ray, Jay Gopal, et al.
Publicado: (2017)

Lipid profile in oral submucous fibrosis
por: Mehrotra, Ravi, et al.
Publicado: (2009)

Medical management of oral submucous fibrosis
por: Shanbhag, Vagish Kumar Laxman
Publicado: (2015)

The role of myofibroblasts in the progression of oral submucous fibrosis: A systematic review
por: Wadhwan, Vijay, et al.
Publicado: (2019)

Management of Oral Submucous Fibrosis with Injection of Hyaluronidase and Dexamethasone in Grade III Oral Submucous Fibrosis: A Retrospective Study
por: James, Leena, et al.
Publicado: (2015)

PTMA, a new identified autoantigen for oral submucous fibrosis, regulates oral submucous fibroblast proliferation and extracellular matrix
por: Wang, Jie, et al.
Publicado: (2017)

Circular RNA-related CeRNA network and prognostic signature for patients with oral squamous cell carcinoma
por: He, Yaodong, et al.
Publicado: (2022)

PTEN and α-SMA Expression and Diagnostic Role in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma with Concomitant Oral Submucous Fibrosis
por: Monteiro, Roshni, et al.
Publicado: (2021)

Submucous fibrosis of the oral cavity. Histomorphological studies.
por: Wahi, P. N., et al.
Publicado: (1966)

Proliferation and apoptosis markers in oral submucous fibrosis
por: Ranganathan, K, et al.
Publicado: (2011)

Oral submucous fibrosis and its dermatological relation
por: Ali, Fareedi Mukram, et al.
Publicado: (2014)

Pathogenesis and therapeutic intervention of oral submucous fibrosis
por: Yoithapprabhunath, Thukanaykanpalayam Ragunathan, et al.
Publicado: (2013)

Immunohistochemical Analysis of Vimentin in Oral Submucous Fibrosis
por: Nayak, Meghanand T., et al.
Publicado: (2013)

Oral submucous fibrosis and plasma lipid profile
por: Pantvaidya, G. H., et al.
Publicado: (2013)

Oral submucous fibrosis: Are we doing enough?
por: Chugh, Ankita, et al.
Publicado: (2019)

Carcinoma Arising in the Background of Oral Submucous Fibrosis
por: Rangaswamy, Shruthi, et al.
Publicado: (2019)

Evaluation of Hematological Profile in Oral Submucous Fibrosis
por: Abidullah, Mohammed, et al.
Publicado: (2022)

Drug treatment for oral submucous fibrosis: an update
por: Chen, Xueru, et al.
Publicado: (2023)

Photobiomodulation therapy inhibits oral submucous fibrosis in mice
por: Chiang, Min‐Hsuan, et al.
Publicado: (2020)

Senescent Fibroblast in Oral Submucous Fibrosis Aids in Disease Progression and Malignant Transformation
por: Karnam, Shyamala, et al.
Publicado: (2022)

Low LINC02147 expression promotes the malignant progression of oral submucous fibrosis
por: Chen, Jun, et al.
Publicado: (2022)

VEGF gene transfection restores the angiogenesis of oral submucous fibrosis in mice
por: Sun, Ying, et al.
Publicado: (2021)

Comparison of Immunohistochemical Markers in Oral Submucous Fibrosis and Oral Submucous Fibrosis Transformed to Oral Squamous Cell Carcinoma—A Systematic Review and Meta-Analysis
por: Mohapatra, Diksha, et al.
Publicado: (2023)

Oral Submucous Fibrosis: A Review on Etiopathogenesis, Diagnosis, and Therapy
por: Shih, Yin-Hwa, et al.
Publicado: (2019)

Buccal fat pad reconstruction for oral submucous fibrosis
por: Surej, Kumar L. K., et al.
Publicado: (2010)

Ultrasonographic Evaluation of Oral Submucous Fibrosis and Masseteric Hypertrophy
por: Devathambi, Jones Raja, et al.
Publicado: (2013)

Prognostic potential of AgNORs in oral submucous fibrosis
por: Murgod, Sanjay, et al.
Publicado: (2016)

Areca nut and its role in oral submucous fibrosis
por: Prabhu, Rachana V., et al.
Publicado: (2014)

Plasma fibrinogen degradation products in oral submucous fibrosis
por: Gupta, Sonia, et al.
Publicado: (2015)

Evaluation of oxidative stress and the microenvironment in oral submucous fibrosis
por: Rai, Vertika, et al.
Publicado: (2019)

Effectiveness of Osteopathic Therapy in the Treatment of Oral Submucous Fibrosis
por: Goyal, Manu, et al.
Publicado: (2017)

Oral submucous fibrosis and COVID-19: Perspective on comorbidity
por: Sarode, Sachin C., et al.
Publicado: (2020)

Determination of Effectiveness of Photobiomodulation in the Treatment of Oral Submucous Fibrosis
por: Sukanya, D., et al.
Publicado: (2022)

The Immunolocalization of Mast Cells in the Pathology of Oral Submucous Fibrosis
por: Gupta, Seema, et al.
Publicado: (2023)

Polyphenol-based targeted therapy for oral submucous fibrosis
por: Mehta, Chetan Hasmukh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ahtq990p4ig2nmu760vf1e7a4c